| Market revenue in 2024 | USD 0.9 billions |
| Market revenue in 2030 | USD 1.3 billions |
| Growth rate | 7.6% (CAGR from 2025 to 2030) |
| Largest segment | Blood tests |
| Fastest growing segment | Blood tests |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD billions |
| Market segmentation | Electrocardiogram, Blood tests |
| Key market players worldwide | GE Healthcare, Hitachi Ltd, Koninklijke Philips NV, MidMark Corporation, Roche Holding AG, SCHILLER, Siemens Healthineers AG ADR, Toshiba Corporation, AstraZeneca PLC |
Publish Date: Mar 11, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hitachi Ltd | View profile | 322,525 | 6-6, Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan, 100-8280 | www.hitachi.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| MidMark Corporation | View profile | 1001-5000 | Dayton, Ohio, United States, North America | www.midmark.com/ |
| Toshiba Corporation | View profile | 10001+ | Tokyo, Tokyo, Japan, Asia | www.toshiba.com/tai/ |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| SCHILLER | View profile | 501-1000 | Feldkirchen, Bayern, Germany, Europe | www.schillermed.de/ |
| GE Healthcare | View profile | 10001+ | Chicago, Illinois, United States, North America | www.gehealthcare.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Heart Attack Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Blood Tests was the largest segment with a revenue share of 55.56% in 2024.
Horizon Databook has segmented the U.K. heart attack diagnostics market based on electrocardiogram, blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Heart Attack Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Heart Attack Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.